Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

SpendMend Launches Trulla Mobile App to Streamline Pharmacy Operations Across Health Systems
Healthcare & PharmaceuticalProduct Announcements

SpendMend Launches Trulla Mobile App to Streamline Pharmacy Operations Across Health Systems

April 24, 2025 9:00 AM

SpendMend, a leading provider of cost cycle management solutions to the healthcare industry, today announced the launch of the Trulla Mobile App, a mobile-first extension of its pharmacy procurement and analytics platform. The new app delivers powerful functionality for pharmacy teams at a Consolidated Services Center (CSC) to process pharmacy orders with greater speed, accuracy, and flexibility - directly from their mobile devices.Built...

Read more
Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally To Bring STEM Education to Students
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally To Bring STEM Education to Students

April 24, 2025 8:30 AM

MilliporeSigma:Curiosity Cube tours North America, Europe, and for the first time, AfricaMobile science lab aims to reach 60,000 students in 19 countriesInteractive lessons on artificial intelligence designed to spark students' curiosity in STEMMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today launched its global 2025 Curiosity Cube tour in Darmstadt,...

Read more
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
Healthcare & PharmaceuticalProduct Announcements

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

April 24, 2025 8:00 AM

Champions Oncology (NASDAQ:CSBR), a global leader in oncology R&D solutions, has announced a strategic collaboration with Turbine, the creators of the world's first interpretable cell simulation platform. This partnership is set to revolutionize biopharma drug discovery workflows by integrating Champions' state-of-the-art multi-omic dataset with Turbine's cutting-edge virtual lab technology.By combining Champions' comprehensively annotated,...

Read more
Netsmart Recognized in 2025 Black Book Post-Acute IT Market Report
Healthcare & PharmaceuticalAwards

Netsmart Recognized in 2025 Black Book Post-Acute IT Market Report

April 24, 2025 8:00 AM

In its 11th consecutive year, Black Book Market Research announces Netsmart as the top-ranked IT vendor in its 2025 Post-Acute Technology Market Report. Based on independent industry-wide surveys, Black Book collected feedback from over 1,300 post-acute care professionals to evaluate niche vendors based on 18 unique key performance indicators (KPIs) that measure operational excellence and client experience."Netsmart is dedicated to investing in...

Read more
World Class Health Announces $10M Funding Round to Transform Care Access
Healthcare & PharmaceuticalCompany Update

World Class Health Announces $10M Funding Round to Transform Care Access

April 24, 2025 8:00 AM

World Class Health, the largest Center of Excellence (CoE) network with U.S. and global reach for large, self-funded employers, today announced the successful closing of a $10M funding round led by Transformation Capital. This milestone comes less than six months after securing $8M in funding and propels the company's mission to transform the patient experience for global healthcare, delivering the highest quality of clinical care, extraordinary...

Read more
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
Healthcare & PharmaceuticalProduct Announcements

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

April 24, 2025 8:00 AM

For decades, the men's health space has remained largely stagnant-held back by legacy brands offering generic solutions and treatment protocols that too often felt like quick fixes rather than genuine care. The result has been an industry shaped by stigma, limited access, and minimal innovation.That landscape is beginning to change. Mangoceuticals Inc. (Nasdaq:MGRX) is taking a different approach, developing products that merge clinical rigor...

Read more
Wellgistics Names Mark DiSiena as New CFO
Healthcare & PharmaceuticalCompany Update

Wellgistics Names Mark DiSiena as New CFO

April 24, 2025 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced a key leadership change to propel Wellgistics Health's strategic growth initiatives forward by appointing Mark DiSiena as its new Chief Financial Officer.As the new Chief Financial Officer of Wellgistics, Mr. DiSiena will oversee...

Read more
San Diego-Based Park Mental Health Treatment Center Explains How the Family Systems Therapy Model Can Heal Families Rooted in Trauma
Healthcare & PharmaceuticalCompany Update

San Diego-Based Park Mental Health Treatment Center Explains How the Family Systems Therapy Model Can Heal Families Rooted in Trauma

April 24, 2025 7:00 AM

The experienced San Diego based therapists at Park Mental Health act as guides to building the skills and understanding necessary to foster healthier relationships. A child's well-being is in the hands of caretakers and parents, but what happens when those hands are harmful? Often rooted in family dynamics, childhood trauma is ground zero for how an adolescent is shaped as an adult and a breeding ground for mental illness.Childhood trauma wreaks...

Read more
LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System
Healthcare & PharmaceuticalRegulatory

LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System

April 24, 2025 6:00 AM

LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Dynamis Robotic Surgical System, marking a significant milestone in the evolution of robotic-assisted hard tissue surgery.The Dynamis Robotic Surgical System is an integrated navigation-based robotic platform designed to enhance the accuracy and control during...

Read more
DEA Marijuana Hypocrisy - Opiate Mission Critical or MMJ Mass Obstruction - Saving Lives?
Healthcare & PharmaceuticalCompany Update

DEA Marijuana Hypocrisy - Opiate Mission Critical or MMJ Mass Obstruction - Saving Lives?

April 24, 2025 5:00 AM

In a recent public forum, Thomas W. Prevoznik, Deputy Assistant Administrator of the Drug Enforcement Administration (DEA), has positioned himself as a champion of public health. At a recent keynote address on substance use disorder and access to opioid treatment, Prevoznik declared: "This is mission critical because at DEA we are here to save lives, just like all of you. And we can't do this alone. We need your collaboration and your...

Read more
Dante Omics AI Unveils DanteNatura.com, Bringing Whole Genome Sequencing to Animals and Plants, A Game-Changer for Farmers, Pet Owners, Breeders, and Researchers in Agrigenomics
Healthcare & PharmaceuticalProduct Announcements

Dante Omics AI Unveils DanteNatura.com, Bringing Whole Genome Sequencing to Animals and Plants, A Game-Changer for Farmers, Pet Owners, Breeders, and Researchers in Agrigenomics

April 24, 2025 3:00 AM

Dante Omics AI, a global pioneer in AI-driven genomics and agrigenomics, proudly announces the launch of Dante Natura (dantenatura.com), an AI-powered platform delivering superior whole genome sequencing (WGS) solutions for animals and plants. Designed to empower farmers, pet owners, breeders, and researchers, Dante Natura harnesses 30X WGS technology to provide actionable genetic insights, driving advancements in agriculture, animal health,...

Read more
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
Healthcare & PharmaceuticalCompany Update

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb

April 24, 2025 1:50 AM

Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced further significant progress of the Company's strategic research collaboration with Bristol Myers Squibb relating to building a high value molecular glue-based pipeline for unmet medical needs. Performance-based and program-based achievements trigger payments of in total US$ 75 m to Evotec.Initiated in 2018, the collaboration combines Evotec's...

Read more
Interim Report January-March 2025
Healthcare & PharmaceuticalEarnings

Interim Report January-March 2025

April 24, 2025 1:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2025 (Jan-Mar)Net sales increased to SEK 218.6 million (186.0), corresponding to growth of 18 percent in SEK and 16 percent in local currencies. Organic growth amounted to 14 percent in local currencies.The Business areas Thoracic and Abdominal delivered sales growth in local currencies: Thoracic 16 percent and Abdominal 28 percent. Services delivered negative growth of -6...

Read more
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds

April 23, 2025 4:41 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 630,376 shares of common stock of the Company originally issued in March 2025, having an...

Read more
The Healthcare of the Future Runs on LLMs - And It’s Already Here
Healthcare & PharmaceuticalCompany Update

The Healthcare of the Future Runs on LLMs - And It’s Already Here

April 23, 2025 1:45 PM

As healthcare systems across the globe grapple with data overload, Avio Health is emerging as a category-defining AI platform reshaping how medical decisions are made. With the launch of its proprietary deep learning engine, Avio is helping physicians turn decades of fragmented health records into precise, real-time clinical insights - in seconds.Trained on vast medical datasets and optimised for real-world clinical workflows, Avio Health...

Read more
Black Book Releases 2025 Report on Vaccine Informatics & Immunization Technology Amid Nationwide Measles Resurgence
Healthcare & PharmaceuticalCompany Update

Black Book Releases 2025 Report on Vaccine Informatics & Immunization Technology Amid Nationwide Measles Resurgence

April 23, 2025 1:30 PM

Black Book Research today announced the release of its comprehensive 2025 Black Book of Vaccine Informatics and Immunization Technology. The study originated as a regional initiative commissioned by a major Texas health system to assess the effectiveness of vaccine IT infrastructure during early measles case surges. As measles outbreaks escalated across the South-Central United States, the research effort expanded nationally to capture the...

Read more
Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
Healthcare & PharmaceuticalCompany Update

Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025

April 23, 2025 10:35 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) Annual Meeting being held May 30 - June 3, 2025.Presentation Details:Presenting Author: Andrew T. Kuykendall, M.D. (Moffitt Cancer Center)Title: Results From VERIFY, a Phase 3, Double-Blind, Placebo (PBO)-Controlled Study of Rusfertide for Treatment of...

Read more
Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System
Healthcare & PharmaceuticalCompany Update

Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System

April 23, 2025 9:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an additional system-wide contract with a US healthcare system. The contract includes an initial order of 65 next-generation TetraGraph systems for monitoring patients under neuromuscular block for use at multiple hospital locations in the Pacific Northwest region."We continue to secure contracts with leading hospitals in the US, and our innovative technology is gaining traction...

Read more
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
Healthcare & PharmaceuticalCompany Update

Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.

April 23, 2025 9:00 AM

Ludwig Enterprises, Inc. (the "Company"), has appointed Charles T. Todd, Jr. as Chief Executive Officer and Chairman of the Board of Directors, to oversee the Company's transition from an innovative research and diagnostic development business to a healthcare solutions provider. Mr. Todd has over 40 years of experience in the Clinical Laboratory Industry in addition to overseeing the growth and development of other innovative healthcare...

Read more
Alpha Genesis, Inc. Offers Immediate Placement for Displaced Research Primates
Healthcare & PharmaceuticalCompany Update

Alpha Genesis, Inc. Offers Immediate Placement for Displaced Research Primates

April 23, 2025 9:00 AM

Alpha Genesis, Inc. (AGI), a national leader in nonhuman primate care and biomedical research support, is offering immediate placement solutions for nonhuman primates affected by programmatic changes in research priorities.As institutions across the country scale back or wind down operations, many are left without clear plans for the long-term care of their primates. AGI is stepping forward to provide safe, accredited housing and continued...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?